Identification of mutation in ASPM gene in microcephaly families from Khyber Pakhtunkhwa

Arsalan Waqas Ahmad Shah1, Laraib Shah2, Fawad Inayat3

  • 1Institute of Health Sciences Swabi, Khyber Medical University, Peshawar, 25000, Pakistan.

PubMed
Abstract

Insights

Microcephaly, a neurodevelopmental disorder, was studied in two Pakistani families. A known ASPM gene mutation caused microcephaly in Family A, while a novel variant in Family B was not linked to the condition.

Area of Science:

  • Genetics
  • Neurodevelopmental Disorders
  • Molecular Biology

Background:

  • Microcephaly is a neurodevelopmental disorder characterized by reduced head circumference and intellectual disability.
  • It has diverse genetic and environmental causes, with ASPM gene mutations accounting for over 40% of cases.
  • ASPM gene mutations are a significant genetic factor in microcephaly pathogenesis.

Purpose of the Study:

  • To investigate the genetic basis of microcephaly in two Pashtun families from Pakistan.
  • To identify mutations in the ASPM gene and assess their pathogenicity.
  • To analyze the impact of identified mutations on ASPM gene expression.

Main Methods:

  • Recruitment of two Pashtun families (A and B) with microcephaly phenotype.
  • Sanger sequencing of the ASPM gene in affected individuals.
  • RNA isolation and analysis of ASPM transcript in Family A.

Main Results:

  • Family A: Identified a known nonsense mutation (c.9557 C>G, p.S3186*) in the ASPM gene, previously linked to microcephaly.
  • This mutation causes mRNA decay, though transcripts may evade nonsense-mediated decay in blood cells.
  • Family B: Identified a novel homozygous variant (c.9316_9316delA) in ASPM, but it did not co-segregate with the phenotype, suggesting it's not the primary cause.

Conclusions:

  • A known ASPM mutation confirms its role in microcephaly in Family A.
  • A novel ASPM variant in Family B was not found to be the primary cause of microcephaly.
  • Further studies, including real-time PCR, are needed to investigate ASPM transcript expression in relevant tissues like the brain.